These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 10609496

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size.
    Abe J, Urano T, Konno H, Erhan Y, Tanaka T, Nishino N, Takada A, Nakamura S.
    Cancer; 1999 Dec 15; 86(12):2602-11. PubMed ID: 10594855
    [Abstract] [Full Text] [Related]

  • 25. Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells.
    Ree AH, Bjørnland K, Brünner N, Johansen HT, Pedersen KB, Aasen AO, Fodstad O.
    Clin Exp Metastasis; 1998 Apr 15; 16(3):205-15. PubMed ID: 9568638
    [Abstract] [Full Text] [Related]

  • 26. Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer.
    Tecimer C, Doering DL, Goldsmith LJ, Meyer JS, Abdulhay G, Wittliff JL.
    Gynecol Oncol; 2001 Jan 15; 80(1):48-55. PubMed ID: 11136569
    [Abstract] [Full Text] [Related]

  • 27. Mouse trophoblastic cell lines: II--Relationship between invasive potential and proteases.
    Sharma RK.
    In Vivo; 1998 Jan 15; 12(2):209-17. PubMed ID: 9627804
    [Abstract] [Full Text] [Related]

  • 28. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.
    Abe T, Mori T, Kohno K, Seiki M, Hayakawa T, Welgus HG, Hori S, Kuwano M.
    Clin Exp Metastasis; 1994 Jul 15; 12(4):296-304. PubMed ID: 8039304
    [Abstract] [Full Text] [Related]

  • 29. The p75(NTR) metastasis suppressor inhibits urokinase plasminogen activator, matrix metalloproteinase-2 and matrix metalloproteinase-9 in PC-3 prostate cancer cells.
    Nalbandian A, Djakiew D.
    Clin Exp Metastasis; 2006 Jul 15; 23(2):107-16. PubMed ID: 16912916
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 and type 2 in stage I malignant melanoma.
    Stabuc B, Markovic J, Bartenjev I, Vrhovec I, Medved U, Kocijancic B.
    Oncol Rep; 2003 Jul 15; 10(3):635-9. PubMed ID: 12684636
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
    Misugi F, Sumi T, Okamoto E, Nobeyama H, Hattori K, Yoshida H, Matsumoto Y, Yasui T, Honda K, Ishiko O.
    Int J Mol Med; 2005 Oct 15; 16(4):541-6. PubMed ID: 16142384
    [Abstract] [Full Text] [Related]

  • 37. Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.
    Iwamoto J, Mizokami Y, Takahashi K, Nakajima K, Ohtsubo T, Miura S, Narasaka T, Takeyama H, Omata T, Shimokobe K, Ito M, Takehara H, Matsuoka T.
    Scand J Gastroenterol; 2005 Jul 15; 40(7):783-93. PubMed ID: 16109653
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Proteinase requirements of epidermal growth factor-induced ovarian cancer cell invasion.
    Ellerbroek SM, Hudson LG, Stack MS.
    Int J Cancer; 1998 Oct 29; 78(3):331-7. PubMed ID: 9766568
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.